News

A recent study led by Andrew Sauer, M.D., cardiologist at Saint Luke’s Mid America Heart Institute, showed that for patients with heart failure, hospital participation in the IMPLEMENT-HF initiative improves patient care.

After a fainting spell, Angela Alvarez was ultimately diagnosed with cardiomyopathy and congestive heart failure. Her original plan of action was to undergo a heart transplant, but she sought a second opinion at Saint Luke’s Mid America Heart Institute.

A local man with heart failure who was told numerous times he only had months to live gets a second chance at life after treatment at Saint Luke's.

When Debbie O’Neal was diagnosed with heart failure at 75, she feared her life was ending. She was the same age that her mother had been when she died of heart disease.

This week we're talking with Dr. Sanjaya Gupta, cardiologist at Saint Luke’s Mid America Heart Institute, about the latest treatment options for this underdiagnosed heart condition.

Ahead of American Heart Month, USA Today talks with Dr. James O’Keefe of the Saint Luke’s Mid America Heart Institute about five steps you can take to reduce your risk of developing heart disease.

According to a new study, higher omega-3 levels significantly reduce the risk of heart failure and heart failure fatalities.

A potassium binder helped patients with heart failure who have or are at high risk for hyperkalemia stay on spironolactone at an optimal dose, but showed a signal of HF hospitalization risk.

Dr. Sanjaya Gupta spoke to KSHB about pulsed field ablation, as well as the second Saint Luke's patient to undergo this innovative new procedure to treat AFib.

A secondary analysis of the pooled STEP-HFpEF and STEP-HFpEF DM trials showed the greatest improvements in those with the most weight loss at 52 weeks.